Matches in Nanopublications for { ?s ?p "[The molecular etiology of this prostate cancer variant is not well understood; however, mutation of the p53 (TP53) tumor suppressor in prostate neuroendocrine cells inactivates the IL8-CXCR2-p53 pathway that normally inhibits cellular proliferation, leading to the development of SCNC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- assertion description "[The molecular etiology of this prostate cancer variant is not well understood; however, mutation of the p53 (TP53) tumor suppressor in prostate neuroendocrine cells inactivates the IL8-CXCR2-p53 pathway that normally inhibits cellular proliferation, leading to the development of SCNC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The molecular etiology of this prostate cancer variant is not well understood; however, mutation of the p53 (TP53) tumor suppressor in prostate neuroendocrine cells inactivates the IL8-CXCR2-p53 pathway that normally inhibits cellular proliferation, leading to the development of SCNC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1248477.RAo1uOSkwMGH4xR7jjvuzBhIh2Nq_vSujSCxlcH4g5VJc130_assertion description "[The molecular etiology of this prostate cancer variant is not well understood; however, mutation of the p53 (TP53) tumor suppressor in prostate neuroendocrine cells inactivates the IL8-CXCR2-p53 pathway that normally inhibits cellular proliferation, leading to the development of SCNC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1248477.RAo1uOSkwMGH4xR7jjvuzBhIh2Nq_vSujSCxlcH4g5VJc130_provenance.
- NP1248478.RArEfJat6-LCW2mff8SKq1PyuXFPYPdR-KJQcsTI6ygB8130_assertion description "[The molecular etiology of this prostate cancer variant is not well understood; however, mutation of the p53 (TP53) tumor suppressor in prostate neuroendocrine cells inactivates the IL8-CXCR2-p53 pathway that normally inhibits cellular proliferation, leading to the development of SCNC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1248478.RArEfJat6-LCW2mff8SKq1PyuXFPYPdR-KJQcsTI6ygB8130_provenance.
- NP1248474.RAFyjAcmq3wvIICX46MQXmaTjTQdtDvUInX9VQJD8zXz8130_assertion description "[The molecular etiology of this prostate cancer variant is not well understood; however, mutation of the p53 (TP53) tumor suppressor in prostate neuroendocrine cells inactivates the IL8-CXCR2-p53 pathway that normally inhibits cellular proliferation, leading to the development of SCNC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1248474.RAFyjAcmq3wvIICX46MQXmaTjTQdtDvUInX9VQJD8zXz8130_provenance.
- NP1248476.RA9VoR3UPF6F5zPW4HC19GUBvkcoKI1JC8_biwPhclZlo130_assertion description "[The molecular etiology of this prostate cancer variant is not well understood; however, mutation of the p53 (TP53) tumor suppressor in prostate neuroendocrine cells inactivates the IL8-CXCR2-p53 pathway that normally inhibits cellular proliferation, leading to the development of SCNC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1248476.RA9VoR3UPF6F5zPW4HC19GUBvkcoKI1JC8_biwPhclZlo130_provenance.